Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$45,000.00

The E3 ligase FBW7 as a cofactor of nuclear receptor transcriptional regulation

FY 2024-25

Summary
Background. Many members of the nuclear receptor family of transcription factors are activated by ligand binding. For example, the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D), signals through the nuclear vitamin D receptor (VDR). We discovered that the 1,25D-bound VDR suppresses expression of the transcription factor cMYC by multiple mechanisms, including, unexpectedly, enhancement of its proteasomal turnover. Thus occurs through formation of a complex of the VDR with cMYC and the E3 ligase FBW7. The VDR and FBW7 interact in a 1,25D-dependent manner, and 1,25D enhances recruitment of the VDR and FBW7 to DNA-bound cMYC, enhancing its proteasomal turnover on chromatin. Surprisingly, we also found that FBW7 was critical for regulation of transcription by the VDR; its knockdown severely impaired VDR transactivation, which occurs via 1,25D-dependent binding to specific DNA motifs called vitamin D response elements (VDREs). It is important to note that, while proteasomal degradation of nuclear receptors has been implicated in their mechanisms of transactivation, our data indicate that the VDR is not a typical FBW7 substrate and that FBW7 does not control VDR stability. Recently, we ablated FBW7 expression by CRISPR/Cas9 genome editing in the 1,25D-sensitive squamous carcinoma line SCC25 and in MCF7 estrogen receptor/progesterone receptor-positive breast cancer cells. These cells also respond to all-trans retinoic acid (ATRA), which signals through related retinoic acid receptors (RARs). We find that ATRA and estradiol-dependent transactivation is also severely impaired in FBW7-depleted cells. Thus, the role of FBW7 in transcriptional regulation by nuclear receptors is not limited to the VDR. Our goals in this program are to characterize FBW7 as a cofactor of nuclear receptor-regulated gene transcription in FBW7 wild-type SCC25 or MCF-7 cells or multiple lines in which FBW7 expression has been knocked out. Specific Aims. -Aim 1. Determine the role of FBW7 in ATRA- and estradiol (E2)-dependent transactivation. We will analyze in full the function of FBW7 as an RAR and ERa cofactor, including its (hormone-dependent) interaction by coimmunoprecipitation, and by chromatin immunoprecipitation (ChIP) and reChIP assays. We will also assess the recruitment of proteasome subunits to DNA-bound receptors, their dependence on FBW7 expression and on hormone, and their role in hormone-dependent transactivation. -Aim 2. Analysis of the effects of FBW7 ablation on nuclear receptor transcriptional regulation. We will perform comparative gene expression profiling studies to determine the effects of FBW7 ablation on nuclear receptor-dependent transactivation and repression by RNAseq in wild-type and engineered SCC25 and MCF-7 cells. -Aim 3. Analysis of the (hormone-dependent) genome-wide distribution of FBW7. We will determine the (hormone-dependent) genome-wide association of FBW7 and nuclear receptors with chromatin by ChIPseq in MCF-7 cells.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2023-04162
Name nom
White, John
Department département
Physiology - Physiology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
45000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
The E3 ligase FBW7 as a cofactor of nuclear receptor transcriptional regulation
Keywords
nuclear receptors; transcriptional regulation; molecular genetics and genomics; transcriptional cofactor; e3 ligase; proteasome
Application summary
Background. Many members of the nuclear receptor family of transcription factors are activated by ligand binding. For example, the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D), signals through the nuclear vitamin D receptor (VDR). We discovered that the 1,25D-bound VDR suppresses expression of the transcription factor cMYC by multiple mechanisms, including, unexpectedly, enhancement of its proteasomal turnover. Thus occurs through formation of a complex of the VDR with cMYC and the E3 ligase FBW7. The VDR and FBW7 interact in a 1,25D-dependent manner, and 1,25D enhances recruitment of the VDR and FBW7 to DNA-bound cMYC, enhancing its proteasomal turnover on chromatin. Surprisingly, we also found that FBW7 was critical for regulation of transcription by the VDR; its knockdown severely impaired VDR transactivation, which occurs via 1,25D-dependent binding to specific DNA motifs called vitamin D response elements (VDREs). It is important to note that, while proteasomal degradation of nuclear receptors has been implicated in their mechanisms of transactivation, our data indicate that the VDR is not a typical FBW7 substrate and that FBW7 does not control VDR stability. Recently, we ablated FBW7 expression by CRISPR/Cas9 genome editing in the 1,25D-sensitive squamous carcinoma line SCC25 and in MCF7 estrogen receptor/progesterone receptor-positive breast cancer cells. These cells also respond to all-trans retinoic acid (ATRA), which signals through related retinoic acid receptors (RARs). We find that ATRA and estradiol-dependent transactivation is also severely impaired in FBW7-depleted cells. Thus, the role of FBW7 in transcriptional regulation by nuclear receptors is not limited to the VDR. Our goals in this program are to characterize FBW7 as a cofactor of nuclear receptor-regulated gene transcription in FBW7 wild-type SCC25 or MCF-7 cells or multiple lines in which FBW7 expression has been knocked out. Specific Aims. -Aim 1. Determine the role of FBW7 in ATRA- and estradiol (E2)-dependent transactivation. We will analyze in full the function of FBW7 as an RAR and ERa cofactor, including its (hormone-dependent) interaction by coimmunoprecipitation, and by chromatin immunoprecipitation (ChIP) and reChIP assays. We will also assess the recruitment of proteasome subunits to DNA-bound receptors, their dependence on FBW7 expression and on hormone, and their role in hormone-dependent transactivation. -Aim 2. Analysis of the effects of FBW7 ablation on nuclear receptor transcriptional regulation. We will perform comparative gene expression profiling studies to determine the effects of FBW7 ablation on nuclear receptor-dependent transactivation and repression by RNAseq in wild-type and engineered SCC25 and MCF-7 cells. -Aim 3. Analysis of the (hormone-dependent) genome-wide distribution of FBW7. We will determine the (hormone-dependent) genome-wide association of FBW7 and nuclear receptors with chromatin by ChIPseq in MCF-7 cells.